Ventolin Evohaler
100mcg
Indicated to address airway narrowing to alleviate symptoms.
Respiratory Health Respiratory medicines include fast-acting relievers and regular controllers. They have different roles, and correct inhaler technique is essential.
100mcg
Indicated to address airway narrowing to alleviate symptoms.
100/50 · 250/50 · 500/50mcg
This inhaler is developed to target chronic obstructive pulmonary disease and is indicated to alleviate airway inflammation.
200mcg
Developed to manage persistent asthma to alleviate airway inflammation.
25/125 · 25/250mcg
Utilized to target asthma and COPD to support respiratory function.
15caps
Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.
Levosalbutamol, Ipratropium Bromide
50/20mcg
Utilized to manage bronchospasm to alleviate respiratory distress.
2 · 4mg
Designed to target airway obstruction to support easier breathing.
100mcg
Indicated to relieve wheezing and formulated to target bronchospasm in asthma and respiratory conditions.
9mcg
Indicated for chronic obstructive pulmonary disease, formulated to alleviate breathing difficulties and support respiratory function in patients managing long-term lung health.
50/250mg
Formulated to alleviate symptoms of asthma and intended to target airway inflammation to support improved respiratory function.
8mg
Indicated to relieve mucus buildup to support respiratory clearance.
400mg
Formulated to mitigate respiratory restriction and indicated to support ease of breathing.
400mg
Formulated to support airway patency by relaxing bronchial smooth muscle cells.
200mg
Designed to target constricted airways, promoting improved airflow and reducing breathing difficulty.
Listings are for comparison only; suitability and supply depend on clinician and pharmacy checks, prescription requirements and the prescribed inhaler device.
Relievers such as salbutamol can act quickly. Inhaled corticosteroids such as budesonide and fluticasone help control airway inflammation. Long-acting medicines include salmeterol and tiotropium. Inhaled delivery can limit, but does not eliminate, whole-body adverse effects.
Uses include asthma and chronic obstructive pulmonary disease. Some nasal or inhaled medicines may also be used for allergic rhinitis, but devices and instructions differ.
Ask a clinician or pharmacist to check inhaler technique and whether a spacer is needed. Do not stop a controller when symptoms improve unless advised. Rinsing the mouth after an inhaled corticosteroid may reduce local adverse effects. Heart conditions, glaucoma, urinary problems and other medicines can affect selection.
Seek emergency help for severe breathlessness, difficulty speaking, blue or grey lips, confusion, exhaustion, chest pain, or symptoms that do not improve after following the prescribed action plan and reliever instructions.
Understand reliever, preventer, AIR and MART inhaler roles—and why ingredients and an asthma action plan matter more than device colour.
Read guide
Understand how a personalised asthma action plan connects daily treatment, early warning signs, reliever instructions and urgent-care decisions.
Read guide
Why symptoms and an antibiotic name cannot identify a bacterial infection—and what diagnosis, allergy, site and resistance change.
Read guide
A practical way to compare multi-symptom cold and flu products by active ingredient and avoid accidentally taking the same medicine twice.
Read guide
Understand how allergy injections and under-the-tongue immunotherapy differ, why testing alone is not enough, and what safety and time commitments matter.
Read guide